Emergent Biosolutions (EBS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | EBS | NGNE | NMRA | ||
| Company | Emergent Biosolutions | Neurogene Inc | Neumora Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NYSE | NASDAQ | NASDAQ | ||
| Open | 8.06 | 26.52 | 2.29 | ||
| High | 8.23 | 27.01 | 2.33 | ||
| Low | 7.99 | 25.32 | 2.23 | ||
| Latest | 8.17 | 25.48 | 2.24 | ||
| Change | +0.18 | -1.00 | -0.01 | ||
| % Change | +2.25% | -3.78% | -0.44% | ||
| Volume | 156,365 | 20,439 | 94,467 | ||
| 20-Day Average Volume | 567,299 | 167,629 | 1,254,036 | ||
| Previous Close | 7.99 | 26.48 | 2.25 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 8.26 | 24.26 | 2.16 | ||
| 20-Day Raw Stochastic | 33.20% | 67.13% | 57.00% | ||
| 20-Day Relative Strength | 45.24 | 57.47 | 46.26 | ||
| Weighted Alpha | +9.97 | -7.56 | -12.30 | ||
| Today's Opinion | 88% Sell | 72% Buy | 8% Sell | ||
| Previous Opinion | 88% Sell | 72% Buy | 8% Sell | ||
| Last Month's Opinion | 56% Sell | 32% Sell | 8% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.93% since 04/23/26 | -4.30% since 04/23/26 | +0.67% since 04/23/26 | ||
| Low | 7.85 on 04/29/26 | 25.32 on 04/30/26 | 2.15 on 04/24/26 | ||
| High | 8.23 on 04/28/26 | 28.58 on 04/28/26 | 2.37 on 04/29/26 | ||
| 1-Month | |||||
| %Chg | +1.43% since 03/30/26 | +33.63% since 03/30/26 | +16.32% since 03/30/26 | ||
| Low | 7.74 on 04/07/26 | 19.13 on 04/13/26 | 1.89 on 03/31/26 | ||
| High | 9.02 on 04/17/26 | 29.05 on 04/17/26 | 2.46 on 04/22/26 | ||
| 3-Month | |||||
| %Chg | -28.00% since 01/30/26 | +46.04% since 01/30/26 | +12.81% since 01/30/26 | ||
| Low | 7.74 on 04/07/26 | 15.93 on 02/05/26 | 1.82 on 03/30/26 | ||
| High | 11.96 on 02/03/26 | 29.05 on 04/17/26 | 3.65 on 02/18/26 | ||
| 6-Month | |||||
| %Chg | -36.41% since 10/30/25 | -22.18% since 10/30/25 | -23.38% since 10/30/25 | ||
| Low | 7.74 on 04/07/26 | 15.93 on 02/05/26 | 1.50 on 01/06/26 | ||
| High | 14.06 on 01/07/26 | 35.47 on 10/31/25 | 3.65 on 02/18/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 412,636 | 413,512 | 411,048 | ||
| Shares Outstanding, K | 51,644 | 15,616 | 182,688 | ||
| Annual Sales | 742,900,000 | 0 | 0 | ||
| Annual Net Income | 52,600,000 | -90,350,000 | -236,930,000 | ||
| Last Quarter Sales | 148,700,000 | 0 | 0 | ||
| Last Quarter Net Income | -54,600,000 | -24,740,000 | -59,450,000 | ||
| 60-Month Beta | 2.35 | 1.56 | 3.08 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.43 on 02/26/26 | -1.12 on 03/24/26 | -0.35 on 03/30/26 | ||
| Earnings Date | 04/30/26 | 05/08/26 | 05/11/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 5.49 | 0.00 | 0.00 | ||